DeutschNewstral
Article
westfaironline.com on 2017-05-23 16:46
FDA approves Regeneron drug Kevzara for rheumatoid arthritis
Related news
FDA Approves Rheumatoid Arthritis Biosimilarwsj.com- Regeneron drug for rheumatoid arthritis approved in Europewestfaironline.com
- FDA approves new Regeneron drug treating severe eczemawestfaironline.com
- FDA approves Regeneron, Sanofi skin cancer immuno-oncology drugwestfaironline.com
FDA approves Regeneron asthma drugbizjournals.com- Big-deal Gilead rheumatoid arthritis drug rejected by FDAbizjournals.com
- FDA Approves Cholesterol Drug From Regeneron, Sanofiwsj.com
FDA Approves Amgen’s RIABNI™ (Rituximab-arrx) for Adults With Moderate to Severe Rheumatoid Arthritisjdsupra.com- MEli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drugmarketwatch.com
- MEli Lilly and Incyte stock drops after FDA fails to approve rheumatoid arthritis drugmarketwatch.com
- FDA grants priority review for Regeneron dermatitis drug for adolescentswestfaironline.com
- FDA rejects J&J application for new rheumatoid arthritis treatmentbizjournals.com
Researchers find rheumatoid arthritis drug is promising coronavirus treatmentNew York Post
FDA approves new drug for Parkinson'sseattletimes.com- Regeneron dermatitis drug approved for European marketwestfaironline.com
- MRoche's rheumatoid arthritis drug fails in COVID-19 trialmarketwatch.com
- Regeneron, Sanofi increase investment in drug developmentswestfaironline.com
- MRegeneron gets FDA approval for Ebola drugmarketwatch.com
- Regeneron receives FDA appoval for Dupixent use for pediatric patientswestfaironline.com
FDA approves first feline arthritis pain treatmentFox News